Literature DB >> 10443162

Heart failure: Part II.

M S Wilkes1, H Middlekauff, J R Hoffman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443162      PMCID: PMC1305689     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  39 in total

Review 1.  Is aspirin safe for patients with heart failure?

Authors:  J G Cleland; C J Bulpitt; R H Falk; I N Findlay; C M Oakley; G Murray; P A Poole-Wilson; C R Prentice; G C Sutton
Journal:  Br Heart J       Date:  1995-09

2.  A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization.

Authors:  J A West; N H Miller; K M Parker; D Senneca; G Ghandour; M Clark; G Greenwald; R S Heller; M B Fowler; R F DeBusk
Journal:  Am J Cardiol       Date:  1997-01-01       Impact factor: 2.778

3.  Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals.

Authors:  E F Philbin; C Andreaou; T A Rocco; L J Lynch; S L Baker
Journal:  Am J Cardiol       Date:  1996-04-15       Impact factor: 2.778

4.  Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission.

Authors:  M Weinberger; E Z Oddone; W G Henderson
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

5.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries.

Authors:  H M Krumholz; E M Parent; N Tu; V Vaccarino; Y Wang; M J Radford; J Hennen
Journal:  Arch Intern Med       Date:  1997-01-13

6.  Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

Authors:  M Packer; W S Colucci; J D Sackner-Bernstein; C S Liang; D A Goldscher; I Freeman; M L Kukin; V Kinhal; J E Udelson; M Klapholz; S S Gottlieb; D Pearle; R J Cody; J J Gregory; N E Kantrowitz; T H LeJemtel; S T Young; M A Lukas; N H Shusterman
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

Review 7.  Rationale for treatment of patients with chronic heart failure with adrenergic blockade.

Authors:  J D Sackner-Bernstein; D M Mancini
Journal:  JAMA       Date:  1995-11-08       Impact factor: 56.272

8.  Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).

Authors:  J J Garguichevich; J L Ramos; A Gambarte; A Gentile; S Hauad; O Scapin; J Sirena; M Tibaldi; J Toplikar
Journal:  Am Heart J       Date:  1995-09       Impact factor: 4.749

9.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

10.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.